Graffinity Pharmaceuticals AG

Main Activity in Nanotechnology

Material Manufacturer

About Company

Graffinity is the premier partner for fragment based drug discovery and lead development of small molecule pharmaceuticals. Graffinity has built an unique approach which includes chemical microarrays, fragment screening, SPR label-free imaging of protein-ligand interactions, computational chemistry and lead discovery. The technology platform offers a new drug discovery paradigm for the rapid conversion of genomic information into novel, high quality leads and drug candidates.

Graffinity applies this technology in established high-profile collaborations with leading Pharma- and Biotech companies.